MedPath

Arsenic Trioxide in Treating Men With Germ Cell Cancer

Phase 2
Completed
Conditions
Extragonadal Germ Cell Tumor
Testicular Germ Cell Tumor
Registration Number
NCT00036842
Lead Sponsor
SWOG Cancer Research Network
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

PURPOSE: Phase II trial to study the effectiveness of arsenic trioxide in treating men who have germ cell cancer that has not responded to previous treatment.

Detailed Description

OBJECTIVES:

* Determine the response rate (confirmed complete and partial responses) in men with refractory testicular or extragonadal germ cell malignancies treated with arsenic trioxide.

* Determine the overall and progression-free survival of patients treated with this drug.

* Determine the qualitative and quantitative toxic effects of this drug in these patients.

* Assess the biomarker response rate in patients with elevated biomarkers treated with this drug.

OUTLINE: This is a multicenter study.

Patients receive arsenic trioxide IV over 1-2 hours on days 1-5. Courses repeat every 28 days for up to 3 years in the absence of disease progression or unacceptable toxicity. Patients who achieve a confirmed complete or partial response receive up to 3 additional courses past response.

Patients are followed every 2 months for 3 years or until disease progression.

PROJECTED ACCRUAL: A total of 20-40 patients will be accrued for this study within 10-40 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (94)

MBCCOP - Gulf Coast

πŸ‡ΊπŸ‡Έ

Mobile, Alabama, United States

CCOP - Western Regional, Arizona

πŸ‡ΊπŸ‡Έ

Phoenix, Arizona, United States

Veterans Affairs Medical Center - Phoenix (Carl T. Hayden)

πŸ‡ΊπŸ‡Έ

Phoenix, Arizona, United States

Veterans Affairs Medical Center - Tucson

πŸ‡ΊπŸ‡Έ

Tucson, Arizona, United States

Arizona Cancer Center at University of Arizona Health Sciences Center

πŸ‡ΊπŸ‡Έ

Tucson, Arizona, United States

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences

πŸ‡ΊπŸ‡Έ

Little Rock, Arkansas, United States

Veterans Affairs Medical Center - Little Rock

πŸ‡ΊπŸ‡Έ

Little Rock, Arkansas, United States

City of Hope Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

Duarte, California, United States

USC/Norris Comprehensive Cancer Center and Hospital

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

Veterans Affairs Medical Center - West Los Angeles

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

Scroll for more (84 remaining)
MBCCOP - Gulf Coast
πŸ‡ΊπŸ‡ΈMobile, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.